Wasatch Advisors Inc Axonics, Inc. Transaction History

Wasatch Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $249,171 - $321,682	5,046 Added 0.72%	704,521 $43.8 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $126,901 - $163,088	2,609 Added 0.37%	699,475 $39.3 Million
Q2 2023 Aug 07, 2023	BUY	$47.99 - $60.21 $8.69 Million - $10.9 Million	181,046 Added 35.1%	696,866 $35.2 Million
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $2.86 Million - $3.66 Million	54,349 Added 11.78%	515,820 $28.1 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $27.5 Million - $35.3 Million	461,471 New	461,471 $28.9 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.